Neoadjuvant therapy (NT) in patients with melanoma is associated with promising survival benefits, favorable complete response (CR), and an acceptable safety profile, according to systematic review ...

Using less ipilimumab appears to make melanoma immunotherapy both safer and more effective, with dramatically better response and survival outcomes. The findings suggest that reducing side effects may ...

Nucana ( ($NCNA) ) has shared an update. On December 10, 2025, NuCana announced the presentation of new clinical data at the ESMO Immuno-Oncology ...

A common, non-invasive skin imaging technique can predict which melanoma patients face a higher risk of metastasis as accurately as current methods that require analyzing tumor samples after surgery.

Metropolitan Dermatology, a leading dermatology group with 22 locations across New Jersey and Staten Island, is pleased to announce that it now offers same-day appointments at most of its centers, ...

Researchers at the University of Arizona awarded federal funding to develop topical treatments that train immune system to ...

FRIDAY, Dec. 12, 2025 (HealthDay News) — Less might be more when it comes to immunotherapy treatment of melanoma, a new study ...

Panelists reflect on clinical experience with immunotherapy combinations, the role of biomarkers, and the future of personalized melanoma treatment. This concluding segment brings together expert ...

Columnist and West Brom fan Adrian Chiles has detailed a recent skin cancer diagnosis and the treatment he had received to ...

The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...

Why it matters: It's reportedly still one of the best-selling songs of all time in any genre, though chart data from decades ...

Flipping the standard doses of nivolumab plus ipilimumab for patients with advanced melanoma may improve survival with less toxicity, a real-world study finds.